ICU Medical (ICUI) Reports In-Line Q4 EPS; Guides FY16 EPS Above Views

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $0.96, in-line with the analyst estimate of $0.96. Revenue for the quarter came in at $90.4 million versus the consensus estimate of $86.57 million.

GUIDANCE:

ICU Medical sees FY2016 EPS of $4.34-$4.46, versus the consensus of $4.20. ICU Medical sees FY2016 revenue of $355-365 million, versus the consensus of $360.7 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c